Welcome to our dedicated page for Milestone Scientific news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific stock.
Milestone Scientific, Inc. (NASDAQ: MLSS) is a pioneering company in the field of medical and dental anesthesia. The company focuses on the development, manufacture, marketing, and sale of computer-controlled local anesthetic delivery (C-CLAD) systems designed to provide improved and painless local anesthetic delivery. These systems are marketed under various trademarks for different applications. For dentistry, the products are known as CompuDent™ and STA™ (Single Tooth Anesthesia) System. These innovative devices allow for painless injections during a wide range of dental procedures, from routine cleanings to complex surgeries involving implants, root canals, and crowns.
For medical applications, Milestone Scientific offers similar technology under the CompuMed™ trademark. Their products are used across various medical disciplines, including plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, and orthopedics. The company's advanced anesthetic delivery systems are sold both in the United States and in over 25 countries worldwide, highlighting their global reach and impact.
Besides their core product offerings, Milestone Scientific also provides The Wand™, a handpiece that allows for almost painless injections, enhancing patient comfort significantly.
The firm's operations are divided into two main segments: Dental and Medical. Geographically, all operations are concentrated in the United States, but their products are influential on a global scale.
Recent Achievements:
- Successful evaluations by prominent medical professionals, such as Dr. Matthew Stottle of Omaha Pain Physicians, achieving 100% success rates.
- Acceleration in reimbursement claims submission for the CompuFlo® Epidural System.
For more information or inquiries, Milestone Scientific can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.
Milestone Scientific (NYSE American: MLSS) has received a Notice of Allowance from the European Patent Office for its innovative CompuFlo instrument, which combines minimum intensity of nerve stimulation and real-time injection pressure monitoring. This technology aims to improve ultrasound-guided peripheral nerve block (PNB) procedures by enhancing needle tip location and reducing injury risks. Developed in collaboration with experts, this advancement positions Milestone for growth in the PNB market, relevant for surgical and postoperative analgesia, with similar patent applications underway in the U.S.
Milestone Scientific (NYSE American:MLSS) has commenced the sale of its CompuFlo® / CathCheck™ disposables to the Medical University of South Carolina (MUSC), the top-ranked hospital in South Carolina. President Arjan Haverhals highlighted that this follows extensive testing by MUSC's team, reflecting a positive reception of the technologies. The CompuFlo system is noted to decrease epidural punctures and save time for anesthesiologists, while the CathCheck technology enhances catheter placement confirmation efficiency. These innovations may offer economic advantages for healthcare institutions.
Milestone Scientific Inc. (MLSS) announced a Notice of Allowance from the USPTO for its new CompuPulse System, which integrates the company's CompuWave™ technology with a manual syringe.
This development aims to enhance drug delivery safety and efficiency by verifying needle and catheter placement, thereby expanding the company's intellectual property and market reach. The CompuPulse System provides a cost-effective alternative for procedures that do not require advanced technology, while ensuring reliable confirmation during injections.
Milestone Scientific (NYSE:MLSS) announced its entry into the German market with the sale of the CompuFlo Epidural Instrument to the University Hospital of Würzburg. This agreement highlights the increasing recognition of the CompuFlo technology, which aims to enhance safety in epidural procedures by reducing accidental dural punctures. The company's leadership expressed optimism about expanding its global presence and accelerating commercialization efforts following this initial order from a prestigious European medical institution.
Milestone Scientific Inc. (MLSS) announced the expansion of its distributor network, signing agreements with Goetze Dental, Midwest Dental Equipment & Supply, and Scott's Dental in the U.S., along with Dental Fix Canada. This growth follows a rapid increase in partnerships, bringing the total to eight distributors in North America in less than a month. CEO Arjan Haverhals indicated that this strategy strengthens their position in the dental market, allowing for accelerated efforts in new global markets.
Milestone Scientific (NYSE: MLSS) announced its participation in the virtual Winter Wonderland Conference, hosted by The MicroCap Rodeo, from February 16th to 19th, 2021. The company’s Interim CEO Leonard Osser and President Jan Adriaan Haverhals will present on February 16th at 3:00 PM ET. The conference features top investment ideas and allows for one-on-one video meetings with qualified institutional investors. Milestone specializes in advanced injection technologies aimed at improving efficiency and patient comfort.
Milestone Scientific Inc. (MLSS) announced two new distribution agreements with Atlanta Dental and Nashville Dental for its Wand® Single Tooth Anesthesia (STA) System. This expands its distribution network in the U.S. to four independent distributors within a month, demonstrating growing market demand for its dental instruments. CEO Arjan Haverhals emphasized the significance of these distributors in boosting sales and supporting dental practices. The company aims to implement a three-year strategy to expand globally and enhance marketing efforts for future growth.
Milestone Scientific (NYSE American: MLSS) announced the receipt of a Notice of Allowance from the USPTO for a patent related to the disposable component of its CompuFlo® Instrument. This patent aims to enhance safety and control through an embedded micro-chip security feature, preventing unauthorized reuse of disposables. Dr. Mark Hochman emphasized the patent's importance for long-term financial success and the company's leadership in the market, holding over 20 related patents.
Milestone Scientific (NYSE American:MLSS) has announced new agreements with US Dental Depot and IQ Dental Supply to distribute its Wand® Single Tooth Anesthesia (STA) System. These agreements enhance coverage in Florida, New York, and New Jersey, indicating a rebound in demand for the product. CEO Arjan Haverhals expressed optimism about the partnerships, while Interim CEO Leonard Osser highlighted a decentralized sales strategy aimed at targeting independent distributors. These moves are expected to drive sales growth in the dental market.
Milestone Scientific (NYSE American: MLSS) has initiated sales of CompuFlo® Epidural and CathCheck disposables to Regional Medical Center (RMC) in South Carolina. This follows successful testing at RMC and aligns with Milestone's strategy to enhance revenue through disposable sales. Interim CEO Leonard Osser noted that the company’s sales pipeline is the strongest in its history, and they aim to establish CompuFlo as the standard in labor and delivery anesthesia across the U.S.
FAQ
What is the current stock price of Milestone Scientific (MLSS)?
What is the market cap of Milestone Scientific (MLSS)?
What does Milestone Scientific, Inc. do?
What are the main products offered by Milestone Scientific?
Where are Milestone Scientific’s products sold?
What recent achievements has Milestone Scientific accomplished?
What are the main segments of Milestone Scientific’s business?
How can Milestone Scientific be contacted?
What is The Wand™?
What is the STA™ System?
Which medical disciplines use Milestone Scientific’s systems?
What is CompuMed™?
